Impact of immune reconstitution inflammatory syndrome on antiretroviral therapy adherence

Patient Preference and Adherence

Volumn 6, Issue , 2012, Pages 887-891

  Nachega, Jean B ^a,b,d   Morroni, Chelsea ^a   Chaisson, Richard E ^b,c,d   Goliath, Rene ^a   Efron, Anne ^d   Ram, Malathi ^b   Maartens, Gary ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Adherence; ART; HIV AIDS; IRIS; TB

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; EFAVIRENZ; NEVIRAPINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ALCOHOL ABUSE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MAJOR CLINICAL STUDY; MALE; PATIENT ATTITUDE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; TUBERCULOSIS; VIRUS LOAD;

EID: 84886036422     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S38897     Document Type: Article

References (18)

1. Badri M, Wilson D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet. 2002;359:2059-2064.
2. Miranda A, Morgan M, Jamal L, et al. Impact of antiretroviral therapy on the incidence of tuberculosis: the Brazilian experience, 1995-2001. PLoS One. 2007;2:e826.
3. Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697-706.
4. Blanc FX, Sok T, Laureillard D, et al. CAMELIA (ANRS 1295-CIPRA KH001) Study Team. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011;365(16): 1471-1481.
5. Havlir DV, Kendall MA, Ive P, et al. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis. N Engl J Med. 2011;365(16): 1482-1491.
6. Nachega JB, Chaisson RE, Goliath R, et al. Randomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy. AIDS. 2010;24:1273-1280.
7. Southern African HIV Clinicians Soceity. Antiretroviral Therapy in Adults, January 2008. South Afr J HIV Med. 2008:18-31. Available from: http://www.hivhotline.uct.ac.za/sahivsoc_guideline_ADULT.pdf. Accessed May 22, 2012.
8. Republic of South Africa Department of Health. National Tuberculosis Management Guidelines. South Africa Department of Health; 2009. Available from: http://familymedicine.ukzn.ac.za/Libraries/Guidelines_Protocols/TB_Guidelines_2009.sflb.ashx. Accessed May 22, 2012.
9. Schag CC, Heinrich RL, Ganz PA. Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncology. 1984; 2:187-193.
10. Meintjes G, Lawn SD, Scano F, et al. International Network for the Study of HIV-associated IRIS. Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis. 2008;8(8):516-523.
11. Haddow LJ, Colebunders R, Meintjes G, et al; International Network for the Study of HIV-associated IRIS (INSHI). Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791-802.
12. Lehloenya R, Meintjes G. Dermatologic manifestations of the immune reconstitution inflammatory syndrome. Dermatol Clin. 2006;24: 549-570.
13. Ewing JA. Detecting alcoholism: The CAGE questionnaire. J Am Med Assoc. 1984;252:1905-1906.
14. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Respir Crit Care Med. 1998;158:157-161.
15. Eshun-Wilson I, Havers F, Nachega JB, et al. Evaluation of paradoxical TB-associated IRIS with the use of standardized case definitions for resource-limited settings. J Int Assoc Physicians AIDS Care (Chic). 2010;9(2):104-108. Epub February 16, 2010.
16. Pepper DJ, Marais S, Maartens G, et al. Neurological manifestations of paradoxical tuberculsosis-associated immune reconstitution inflammatory syndrome: a case series. Clin Infec Dis. 2009;48:e96-e107.
17. Lawn S, Meinjtjes G. Pathogenesis and prevention of immune reconstitution disease during antiretroviral therapy. Expert Rev Anti Infect Ther. 2011;9(4):415-430.
18. Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med. 2012;156:817-833.